Lisa Tachiki

Hematology | Oncology

825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

From surgery to systemic therapy in von Hippel-Lindau disease: insights from extended follow-up of LITESPARK-004.

From surgery to systemic therapy in von Hippel-Lindau disease: insights from extended follow-up of LITESPARK-004.

Journal: Translational andrology and urology

Published: August 28, 2025

Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.

Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients.

Journal: BMJ oncology

Published: October 30, 2024

Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.

Intratumoral STING agonist reverses immune evasion in PD-(L)1-refractory Merkel cell carcinoma: mechanistic insights from detailed biomarker analyses.

Journal: Journal for immunotherapy of cancer

Published: September 20, 2024

Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review.

Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review.

Journal: Future oncology (London, England)

Published: September 11, 2024

Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes.

Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes.

Journal: Cancers

Published: June 15, 2024

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.

Journal: Cancer

Published: June 26, 2023

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.

Journal: medRxiv : the preprint server for health sciences

Published: May 19, 2023

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.

COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.

Journal: Translational oncology

Published: December 03, 2022

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.

Journal: JAMA oncology

Published: November 03, 2022

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.

Journal: BMC cancer

Published: September 09, 2022

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.

Journal: eLife

Published: August 11, 2022

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.

Journal: Cancers

Published: July 16, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026